Effects of Supplementation With Linseed Oil on Blood Lipids in Vegetarians

October 5, 2022 updated by: Gerhard Jahreis, University of Jena

Effects of Supplementation With Linseed Oil on Blood Lipids and Fatty Acid Profile in Plasma and Erythrocyte Lipids in Vegetarians

The study was performed to investigate the effects of a daily consumption of linseed oil on fatty acid distribution in plasma and red blood cell lipids and blood lipids in vegetarians.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Recent studies suggest that the daily intake of n-3 LC-PUFA (EPA and DHA) can modulate cardiovascular risk factors and prevent lifestyle diseases.

The major dietary source of EPA and DHA is seafood (seaweeds and fatty cold water fishes), but they can also be found in lean red meat, in organ meats such as liver and brain. Vegetarians who do not eat meat or fish, have very low or negligible intakes of EPA (< 5 mg EPA/d) and DHA.

The purpose of the present study is to explore the tissue distribution and inter-conversion of ALA to n-3 LC-PUFA as consequence of linseed oil supplementation in vegetarians.

Eight vegetarians (3 m; 5 f) who do not eat meat, fish or seaweeds such as algae foods since least two years ago and two subjects (1 m; 1w) who consume the normal western style diet living in Jena (Germany) entered the study. The participants consumed 10 mL linseed oil per day for 10 weeks. The resulting daily dose of ALA was approx. 5.7 g/d.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • for the vegetarian sub-group : vegetarian diet pattern

Exclusion Criteria:

  • high performance sport, daily alcohol intake and the in-take of dietary supplements (e.g., fish oil capsules)
  • for the vegetarian sub-group, the consumption of fish and algae products (e.g. seaweeds, sushi)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vegetarians
Dietary supplement: 10 mL linseed oil per day
Dietary supplement: 10 mL linseed oil per day
Placebo Comparator: Omnivores
Dietary supplement: 10 mL linseed oil per day
Dietary supplement: 10 mL linseed oil per day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
EPA concentrations in plasma lipids and red blood cell lipids
Time Frame: 10 weeks
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood lipids
Time Frame: 10 weeks
total cholesterol, triacylglycerides, high density cholesterol, low density cholesterol, lipoprotein a
10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
parameters of iron status
Time Frame: 10 weeks
transferrin, ferritin, transferrin saturation, total ferritin
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

November 1, 2009

Study Completion (Actual)

December 1, 2009

Study Registration Dates

First Submitted

February 6, 2013

First Submitted That Met QC Criteria

February 7, 2013

First Posted (Estimate)

February 11, 2013

Study Record Updates

Last Update Posted (Actual)

October 10, 2022

Last Update Submitted That Met QC Criteria

October 5, 2022

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • H39_09

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Linseed oil

3
Subscribe